title: Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.
abstract: Disruption of the GABAergic system has been implicated in multiple developmental disorders, including epilepsy, autism spectrum disorder and schizophrenia. The human gene encoding uPAR (PLAUR) has been shown recently to be associated with the risk of autism. The uPAR(-/-) mouse exhibits a regionally-selective reduction in GABAergic interneurons in frontal and parietal regions of the cerebral cortex as well as in the CA1 and dentate gyrus subfields of the hippocampus. Behaviorally, these mice exhibit increased sensitivity to pharmacologically-induced seizures, heightened anxiety, and atypical social behavior. Here, we explore potential alterations in GABAergic circuitry that may occur in the context of altered interneuron development. Analysis of gene expression for 13 GABA(A) receptor subunits using quantitative real-time polymerase chain reaction (PCR) indicates seven subunit mRNAs (alpha(1), alpha(2), alpha(3), beta(2), beta(3), gamma(2S) and gamma(2L)) of interest. Semi-quantitative in situ hybridization analysis focusing on these subunit mRNAs reveals a complex pattern of potential gene regulatory adaptations. The levels of alpha(2) subunit mRNAs increase in frontal cortex, CA1 and CA3, while those of alpha3 decrease in frontal cortex and CA1. In contrast, alpha(1) subunit mRNAs are unaltered in any region examined. beta(2) subunit mRNAs are increased in frontal cortex whereas beta(3) subunit mRNAs are decreased in parietal cortex. Finally, gamma(2S) subunit mRNAs are increased in parietal cortex while gamma(2L) subunit mRNAs are increased in the dentate gyrus, potentially altering the gamma(2S):gamma(2L) ratio in these two regions. For all subunits, no changes were observed in forebrain regions where GABAergic interneuron numbers are normal. We propose that disrupted differentiation of GABAergic neurons specifically in frontal and parietal cortices leads to regionally-selective alterations in local circuitry and subsequent adaptive changes in receptor subunit composition. Future electrophysiological studies will be useful in determining how alterations in network activity in the cortex and hippocampus relate to the observed behavioral phenotype.
authors.affiliation: Zilkha Neurogenetic Institute and Department of Cell and Neurobiology, Keck School of Medicine at University of Southern California, 1501 San Pablo Street, Los Angeles, CA 90033, USA. keagleso@usc.edu
authors.forename: K L
authors.initials: KL
authors.lastname: Eagleson
authors.forename: M C
authors.initials: MC
authors.lastname: Gravielle
authors.forename: L J
authors.initials: LJ
authors.lastname: Schlueter McFadyen-Ketchum
authors.forename: S J
authors.initials: SJ
authors.lastname: Russek
authors.forename: D H
authors.initials: DH
authors.lastname: Farb
authors.forename: P
authors.initials: P
authors.lastname: Levitt
mesh_terms: D000818:Animals; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000235:genetics*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D021122:Protein Subunits / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D011963:Receptors, GABA-A / Q000096:biosynthesis* / Q000235:genetics; D055293:Receptors, Urokinase Plasminogen Activator / Q000235:genetics / Q000502:physiology*; D013687:Telencephalon / Q000378:metabolism*
chemical_list: C524899:Plaur protein, mouse; D021122:Protein Subunits; D012333:RNA, Messenger; D011963:Receptors, GABA-A; D055293:Receptors, Urokinase Plasminogen Activator
references.citation: J Pharmacol Exp Ther. 1997 Oct;283(1):350-7
references.pmid: 9336343
references.citation: J Chem Neuroanat. 2001 Jul;22(1-2):95-100
references.pmid: 11470557
references.citation: Am J Psychiatry. 2008 Apr;165(4):479-89
references.pmid: 18281411
references.citation: J Neurosci. 2003 Dec 17;23(37):11711-24
references.pmid: 14684873
references.citation: Neuroscience. 2007 Dec 5;150(2):370-85
references.pmid: 17950542
references.citation: Int Rev Neurobiol. 2007;78:109-31
references.pmid: 17349859
references.citation: Hum Mol Genet. 2007 Mar 15;16(6):691-703
references.pmid: 17339270
references.citation: J Biol Chem. 1992 Jul 15;267(20):14470-6
references.pmid: 1321150
references.citation: Hum Mol Genet. 2005 Feb 15;14(4):483-92
references.pmid: 15615769
references.citation: J Comp Neurol. 2003 Dec 22;467(4):581-92
references.pmid: 14624490
references.citation: J Neurochem. 1994 Jul;63(1):301-9
references.pmid: 8207435
references.citation: Neuropsychopharmacology. 2003 Nov;28(11):1950-9
references.pmid: 12888776
references.citation: J Neurosci. 2003 Jul 16;23(15):6315-26
references.pmid: 12867516
references.citation: Biol Psychiatry. 2009 Jun 15;65(12):1015-23
references.pmid: 19249749
references.citation: J Comp Neurol. 2005 Sep 5;489(4):449-66
references.pmid: 16025458
references.citation: Science. 2004 Mar 12;303(5664):1678-81
references.pmid: 15017001
references.citation: Mol Cell Neurosci. 2007 Jun;35(2):220-9
references.pmid: 17433713
references.citation: J Neurosci. 2009 Aug 26;29(34):10695-705
references.pmid: 19710321
references.citation: Ann Neurol. 2001 Jan;49(1):67-78
references.pmid: 11198298
references.citation: Mol Psychiatry. 2008 Feb;13(2):147-61
references.pmid: 17471287
references.citation: Neuroreport. 2003 Sep 15;14(13):1731-5
references.pmid: 14512847
references.citation: Mol Pharmacol. 1995 Nov;48(5):861-8
references.pmid: 7476917
references.citation: J Child Neurol. 2006 Dec;21(12):1058-63
references.pmid: 17156698
references.citation: Biol Psychiatry. 2008 May 15;63(10):953-62
references.pmid: 17988653
references.citation: Neuroimage. 2004 May;22(1):22-8
references.pmid: 15109994
references.citation: Arch Gen Psychiatry. 2000 Mar;57(3):237-45
references.pmid: 10711910
references.citation: Am J Hum Genet. 2005 Sep;77(3):377-88
references.pmid: 16080114
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2004 Nov 15;131B(1):51-9
references.pmid: 15389768
references.citation: Pharmacol Biochem Behav. 2000 Jun;66(2):371-4
references.pmid: 10880692
references.citation: Nat Neurosci. 2005 Aug;8(8):1059-68
references.pmid: 16007083
references.citation: J Neural Transm (Vienna). 2002 May;109(5-6):881-9
references.pmid: 12111475
references.citation: Epilepsia. 2005;46 Suppl 7:22-8
references.pmid: 16201992
references.citation: Neuropharmacology. 1996;35(9-10):1457-63
references.pmid: 9014161
references.citation: Autism Res. 2009 Aug;2(4):205-19
references.pmid: 19650112
references.citation: Ann Hum Genet. 2006 May;70(Pt 3):281-92
references.pmid: 16674551
references.citation: Neuron. 1994 May;12(5):1081-95
references.pmid: 8185945
references.citation: J Neurosci. 2008 Feb 20;28(8):1904-15
references.pmid: 18287507
references.citation: Pharmacol Biochem Behav. 2000 Aug;66(4):887-92
references.pmid: 10973530
references.citation: Dev Biol. 2008 Jan 15;313(2):648-58
references.pmid: 18054781
references.citation: Nat Med. 1998 Oct;4(10):1166-72
references.pmid: 9771750
references.citation: Neuron. 2009 Aug 27;63(4):466-81
references.pmid: 19709629
references.citation: Physiol Behav. 2002 Dec;77(4-5):595-600
references.pmid: 12527005
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4275-80
references.pmid: 16537521
references.citation: Neuroscience. 2005;132(2):399-407
references.pmid: 15802192
references.citation: Neuropediatrics. 2003 Aug;34(4):169-76
references.pmid: 12973656
references.citation: Cereb Cortex. 2006 Jan;16(1):47-63
references.pmid: 15829735
references.citation: Mol Cell Neurosci. 2003 Oct;24(2):442-50
references.pmid: 14572465
references.citation: Neuroscience. 1999;93(1):33-44
references.pmid: 10430468
references.citation: Int J Neuropsychopharmacol. 2008 Nov;11(7):891-903
references.pmid: 18364065
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5942-7
references.pmid: 19293383
references.citation: Cell Tissue Res. 2006 Nov;326(2):505-16
references.pmid: 16937111
references.citation: Cereb Cortex. 2009 Jul;19 Suppl 1:i22-31
references.pmid: 19366869
references.citation: Cereb Cortex. 2002 Oct;12(10):1063-70
references.pmid: 12217970
references.citation: Epilepsia. 2006 Oct;47(10):1655-64
references.pmid: 17054688
references.citation: Brain. 2006 Dec;129(Pt 12):3277-89
references.pmid: 17046856
references.citation: J Neurosci. 1994 Sep;14(9):5302-24
references.pmid: 8083738
references.citation: Neuroscience. 2005;134(2):691-704
references.pmid: 15951123
references.citation: Trends Neurosci. 2004 Jul;27(7):400-6
references.pmid: 15219739
references.citation: Brain Res. 2007 Apr 6;1140:75-83
references.pmid: 16996039
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(24):9966-70
references.pmid: 1702226
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15066-71
references.pmid: 9844016
references.citation: J Neurodev Disord. 2009 Sep;1(3):224-36
references.pmid: 19816534
references.citation: Cereb Cortex. 1995 Nov-Dec;5(6):550-60
references.pmid: 8590827
references.citation: J Neurosci. 2002 Apr 1;22(7):2718-29
references.pmid: 11923437
references.citation: Nat Neurosci. 2009 Aug;12(8):1020-7
references.pmid: 19620975
references.citation: Thromb Haemost. 2007 Mar;97(3):336-42
references.pmid: 17334498
references.citation: Brain Res. 2004 Jul 30;1016(1):1-11
references.pmid: 15234246
references.citation: Curr Opin Neurobiol. 2007 Feb;17(1):103-11
references.pmid: 17275283
references.citation: Nat Neurosci. 2005 Jun;8(6):797-804
references.pmid: 15895085
references.citation: Hippocampus. 2000;10(3):305-24
references.pmid: 10902900
references.citation: Brain Res. 2006 Nov 22;1121(1):238-45
references.pmid: 17046729
references.citation: Autism Res. 2008 Jun;1(3):159-68
references.pmid: 19360663
references.citation: J Neurosci. 2009 Jul 8;29(27):8752-63
references.pmid: 19587282
references.citation: Nat Rev Neurosci. 2005 Apr;6(4):312-24
references.pmid: 15803162
references.citation: Nat Neurosci. 1998 Nov;1(7):563-71
references.pmid: 10196563
references.citation: J Neurobiol. 2002 Feb 5;50(2):137-49
references.pmid: 11793360
references.citation: J Neurosci. 2003 Jan 15;23(2):622-31
references.pmid: 12533622
references.citation: Science. 2004 Mar 12;303(5664):1681-3
references.pmid: 15017002
references.citation: Neuroscience. 1997 Jul;79(2):477-87
references.pmid: 9200730
references.citation: Neuroscience. 1999;91(1):327-41
references.pmid: 10336082
references.citation: Eur J Pharmacol. 2002 Jun 20;446(1-3):201-2
references.pmid: 12098603
references.citation: Psychopharmacology (Berl). 2005 Jul;180(2):191-205
references.pmid: 15864560
references.citation: J Med Genet. 2006 May;43(5):429-34
references.pmid: 16556609
references.citation: Genes Brain Behav. 2003 Oct;2(5):255-67
references.pmid: 14606691
references.citation: Behav Brain Res. 2010 Jan 5;206(1):32-7
references.pmid: 19716847